- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01778309
NAC Supplementation and Skeletal Muscle Performance
Effects of NAC Supplementation on Skeletal Muscle Performance Following Aseptic Injury Induced by Exercise
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The major thiol-disulfide couple of reduced (GSH) and oxidized glutathione (GSSG) is a key-regulator of major transcriptional pathways regulating aseptic inflammation and recovery of skeletal muscle following aseptic injury. Antioxidant supplementation may hamper exercise-induced cellular adaptations.
Our objective was to examine how thiol-based antioxidant supplementation affects skeletal muscle's performance and redox-sensitive signalling during the inflammatory and repair phases associated with exercise-induced micro-trauma.In a double-blind, counterbalanced design, 12 men received placebo (PLA) or N-acetylcysteine (NAC, 20 mg/kg/day) following muscle-damaging exercise (300 eccentric contractions). In each trial, muscle performance was measured at baseline, post-exercise, 2h post-exercise and daily for 8 consecutive days. Muscle biopsies from vastus lateralis and blood samples were collected pre-exercise and 2h, 2d, and 8d post-exercise.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Thrace
-
Komotini, Thrace, Greece, 69100
- Laboratory of Physical Education & Sport Performance
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
a) recreationally trained as evidenced by their maximal oxygen consumption levels (VO2max >45 ml/kg/min), b) were engaged in systematic exercise at least three times/week for ≥12 months), c) non-smokers, d) abstained from any vigorous physical activity during the study, e)abstained from consumption of caffeine, alcohol, performance-enhancing or antioxidant supplements, and medications during the study.
Exclusion Criteria:
a) a known NAC intolerance or allergy, b) a recent febrile illness, c) history of muscle lesion, d) lower limb trauma
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: n-acetylcysteine/placebo supplementation
n-acetylcysteine supplementation, orally in three daily dosages, at 20 mg/kg/day, daily for eight days after exercise placebo, orally in three daily dosages, content: 500 mL drink that contained water (375 mL), sugar-free cordial (125 ml), and 2 g of low-calorie glucose/dextrose powder.
|
n-acetylcysteine administration: 20 mg//kg/day, orally, daily for eight days following exercise placebo administration: 500 mL orally, daily for eight days following exercise
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in reduced glutathione in blood
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
Concentration of reduced glutathione in red blood cells
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
Change in reduced glutathione in muscle
Time Frame: one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
concentration of reduced glutathione in quadriceps skeletal muscle group
|
one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
|
Change in protein carbonyls in red blood cells and serum
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
concentration of protein carbonyls
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
Change in protein carbonyls in muscle
Time Frame: one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
protein carbonyl concentration in vastus lateralis skeletal muscle
|
one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
|
Change in thiobarbituric acid reactive substances in red blood cells and serum
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
thiobarbituric acid reactive substances concentration in serum and red blood cells
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
Change in thiobarbituric acid reactive substances in muscle
Time Frame: one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
thiobarbituric acid reactive substances concentration in vastus lateralis skeletal muscle
|
one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
|
Change in oxidized glutathione in red blood cells and blood
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
Concentration of oxidized glutathione in red blood cells and whole blood
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
Change in total antioxidant capacity in serum
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
|
Change in oxidized glutathione in muscle
Time Frame: one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
concentration of oxidized glutathione in vastus lateralis skeletal muscle
|
one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
|
Change in catalase activity in red blood cells and serum
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
|
Change in glutathione peroxidase activity in red blood cells
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
|
Change in creatine kinase activity in plasma
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
|
Change in C-reactive protein in plasma
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
|
Change in macrophage infiltration in muscle
Time Frame: one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
|
|
Change in white blood cell count in blood
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
|
Change in neutrophil count in blood
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
|
Change in fatty acid binding protein in plasma
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
|
Change in cortisol concentration in blood
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
|
Change in testosterone concentration in plasma
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
|
Change in cytokine concentration in plasma
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
Measurement of IL-1β, IL-4, IL-6, TNF-α, IL-8, IL-10, IL-12p70 concentrations in plasma
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
Change in adhesion molecule concentration in blood
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
Measurement of ICAM-1, VCAM-1, sP-selectin, sE-selectin concentrations in plasma
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
Change in intracellular signalling proteins in muscle
Time Frame: one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
Measurement of phosphorylation levels of protein kinase B (Akt), mammalian target of rapamycin (mTOR), serine/threonine kinase (p70S6K), ribosomal protein S6 (rpS6), nuclear factor κB (NFκB), serine⁄threonine mitogen activated protein kinase (p38-MAPK) in vastus lateralis muscle.
|
one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
|
Change in myogenic determination factor (MyoD) protein levels in muscle
Time Frame: one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
MyoD expression in vastus lateralis muscle
|
one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
|
Change in tumor necrosis factor α in muscle
Time Frame: one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
Protein levels of TNF-α in vastus lateralis muscle
|
one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in muscle function of knee extensor and flexor muscle
Time Frame: one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
assessment of muscle peak and mean torque of knee extensors and flexors on an isokinetic dynamometer at 0, 90 and 180 degrees/sec
|
one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise
|
|
Body composition
Time Frame: One day before exercise
|
Assessment of percent (%) lean body mass.
|
One day before exercise
|
|
Maximal aerobic capacity
Time Frame: One day before exercise
|
Assessment of maximal oxygen consumption, an indice of cardiovascular conditioning
|
One day before exercise
|
|
Change in profile of dietary intake
Time Frame: one hour before exercise, daily for 8 days post-exercise
|
Assessment of dietary intake with emphasis on antioxidant element intake
|
one hour before exercise, daily for 8 days post-exercise
|
|
Change in side effect occurence
Time Frame: one hour before exercise, daily for 8 days post-exercise
|
The prevalence of potential side-effects (such as headaches or abdominal pain or any other discomfort) was monitored using a subjective 0-10 side-effects scale on a daily bases by an unblinded investigator (for ethical reasons).
|
one hour before exercise, daily for 8 days post-exercise
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ioannis F Fatouros, Ph.D., Democritus University of Thrace, Greece
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NACEXERCISE2011
- CE-80739 (Other Identifier: Tzelalis Sports Medicine co.)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skeletal Muscle Performance
-
University of Nove de JulhoCompletedSkeletal Muscle PerformanceBrazil
-
University of ManitobaRecruitingSkeletal Muscle | Human PerformanceCanada
-
University of ThessalyCompletedAthletic Performance | Muscle Damage | Skeletal Muscle DamageGreece
-
Poznan University of Life SciencesRecruitingSkeletal Muscle Performance | Gene PolymorphismsPoland
-
University of ThessalyCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Exercise-induced Aseptic Inflammation | Intracellular Signaling in Skeletal Muscle | Proteasome ActivationGreece
-
University of ThessalyCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Exercise-induced Aseptic Inflammation | Antioxidant StatusGreece
-
University of ThessalyCompletedPerformance | Skeletal Muscle Damage | Exercise-induced Aseptic InflammationGreece
-
University of ThessalyCompletedMuscle Inflammation | Skeletal Muscle Damage | Soccer Performance | Muscle RecoveryGreece
-
IpsenCompletedUpper Limb Spasticity (Altered Skeletal Muscle Performance) in ChildrenUnited States, Poland, Spain, Belgium, Israel, Turkey, Czechia, Mexico
Clinical Trials on n-acetylcysteine supplementation
-
Nacuity Pharmaceuticals, Inc.Not yet recruitingUsher Syndrome | Retinitis Pigmentosa (RP)
-
University of GaziantepCompletedCOVID-19-Associated Acute Respiratory Distress Syndrome (ARDS)Turkey (Türkiye)
-
Institut d'Anesthesiologie des Alpes MaritimesCompleted
-
University of Sao Paulo General HospitalCompleted
-
Indiana UniversityBioAdvantex PharmaCompletedHIV | Endothelial Dysfunction | Oxidative StressUnited States
-
Assaf-Harofeh Medical CenterUnknownChronic Kidney Diseases | General AnesthesiaIsrael
-
Medical University of South CarolinaCompleted
-
South Valley UniversityCompletedIntoxication | N-Acetylcysteine | Urine Alkalinization | Hair Dye | Paraphenylene DiamineEgypt
-
Rajavithi HospitalCompletedChemotherapy-induced Peripheral NeuropathyThailand
-
University of ChicagoNational Institute on Drug Abuse (NIDA); University of MinnesotaCompletedTobacco Use Disorder | GamblingUnited States